Truist Raises Vertex (VRTX) Price Target Following Phase 3 Trial Results.
Share this article
Earnings
Score 65
Bullish
Truist Raises Vertex (VRTX) Price Target Following Phase 3 Trial Results
Mar 24, 2026 11:27 UTC
VRTX, XLV, IHI
Short term
Related Articles
Score 65
Bullish
Resilience of Travel Boosted Hilton Worldwide Holdings (HLT) in Q4
Mar 24, 13:40
Score 45
Bullish
Brown Advisory Mid-Cap Growth Strategy Bets on Medline (MDLN) in IPO
Mar 24, 13:34
Score 45
Everpure (PSTG) was Volatile Despite Strong Results
Mar 24, 13:27
Score 45
Bullish
Retailer Kingfisher posts higher profit as UK&I growth offsets softer markets
Mar 24, 13:21
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.